{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:34:28Z","timestamp":1792809268980,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd009881","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T00:00:00Z","timestamp":1500940800000}}],"reference-count":42,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009881.pub2","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T22:15:31Z","timestamp":1513808131000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Progesterone receptor modulators for endometriosis"],"prefix":"10.1002","volume":"2017","author":[{"given":"Jing","family":"Fu","sequence":"first","affiliation":[{"name":"West China Second University Hospital, Sichuan University; Department of Obstetrics and Gynecology; Chengdu Sichuan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Song","sequence":"additional","affiliation":[{"name":"West China Second University Hospital, Sichuan University; Department of Obstetrics and Gynecology; Chengdu Sichuan China"},{"name":"Ministry of Education; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University); Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[{"name":"West China Second University Hospital, Sichuan University; Department of Obstetrics and Gynecology; Chengdu Sichuan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Zhu","sequence":"additional","affiliation":[{"name":"West China Second University Hospital, Sichuan University; Department of Obstetrics and Gynecology; Chengdu Sichuan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhe","family":"Wang","sequence":"additional","affiliation":[{"name":"West China Second University Hospital, Sichuan University; Department of Obstetrics and Gynecology; Chengdu Sichuan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengxi","family":"Chen","sequence":"additional","affiliation":[{"name":"West China Second University Hospital, Sichuan University; Department of Obstetrics and Gynecology; Chengdu Sichuan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[{"name":"West China Second University Hospital, Sichuan University; Department of Obstetrics and Gynecology; Chengdu Sichuan China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,7,25]]},"reference":[{"key":"10.1002\/14651858.CD009881.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/01443619509015498","article-title":"A multicentre comparative study of gestrinone and danazol in the treatment of endometriosis","volume":"15","author":"Bromham","year":"1995","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1471-0528.1995.tb09160.x","article-title":"Updating the clinical experience in endometriosis - the European perspective","volume":"102 Suppl 12","author":"Bromham","year":"1995","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD009881.pub2-BIB0003|cit3","first-page":"51","article-title":"Treatment with 5 mg or 25 mg of mifepristone daily for six months. A randomized double-blind study","volume":"55","author":"Carbonell","year":"2012","journal-title":"Progresos de Obstetricia y Ginecologia"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jrhm.2015.09.001","article-title":"Mifepristone 2.5, 5, 10 mg versus placebo in the treatment of endometriosis","volume":"2","author":"Carbonell","year":"2016","journal-title":"Journal of Reproductive Health and Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD009881.pub2-BIB0005|cit5","first-page":"S83","article-title":"Treatment of endometriosis with the novel selective progesterone receptor modulator (SPRM) asoprisnil","volume":"82","author":"Chwalisz","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD009881.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0002-9378(97)70504-0","article-title":"Clinical, endocrine, and metabolic effects of two doses of gestrinone in treatment of pelvic endometriosis","volume":"176","author":"Dawood","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0015-0282(16)60666-0","article-title":"Gestrinone versus danazol in the treatment of endometriosis","volume":"51","author":"Fedele","year":"1989","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0015-0282(16)58682-8","article-title":"Gestrinone versus a gonadotropin releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomised, double-blind study","volume":"66","author":"Gestrinone Italian Study Group","year":"1996","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0015-0282(16)53273-7","article-title":"A randomised, double-blind prospective trial of two doses of gestrinone in the treatment of endometriosis","volume":"53","author":"Hornstein","year":"1990","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0011|cit10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/GCO.0b013e32832e07e8","article-title":"Clinical utility of progesterone receptor modulators and their effect on the endometrium","volume":"21","author":"Spitz","year":"2009","journal-title":"Current Opinion in Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0010|cit11","article-title":"Progesterone receptor modulators in endometriosis: a new therapeutic option","volume-title":"Textbook of Endometriosis","author":"Spitz","year":"2009"},{"issue":"3","key":"10.1002\/14651858.CD009881.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0015-0282(16)55793-8","article-title":"A randomized comparative study of the metabolic effects of two regimens of gestrinone in the treatment of endometriosis","volume":"59","author":"Worthington","year":"1993","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0013|cit13","unstructured":"Bulun S Ulipristal for endometriosis-related pelvic pain ClinicalTrials.gov Identifier:NCT02213081"},{"issue":"1","key":"10.1002\/14651858.CD009881.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0015-0282(16)58022-4","article-title":"Treatment of endometriosis with the antiprogesterone mifepristone (RU486)","volume":"65","author":"Kettel","year":"1996","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0002-9378(98)70316-3","article-title":"Preliminary report on the treatment of endometriosis with low dose mifepristone (RU 486)","volume":"178","author":"Kettel","year":"1998","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0016|cit16","first-page":"33","article-title":"Three-step therapy of genital endometriosis in cases of human infertility with lynestrenol, danazol or gestrinone administration in the second step","volume-title":"Medical Management of Endometriosis","author":"Mettler","year":"1984"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0017|cit17","first-page":"199","article-title":"Long term follow-up of endometriosis after two different therapies (gestrinone and buserelin)","volume":"23","author":"Nieto","year":"1996","journal-title":"Clinical & Experimental Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1471-0528.1980.tb04607.x","article-title":"Treatment of endometriosis: a study of medical management","volume":"87","author":"Noble","year":"1980","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/bmj.294.6567.272","article-title":"Impact of gestrinone on the course of asymptomatic endometriosis","volume":"294","author":"Thomas","year":"1987","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD009881.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF02836527","article-title":"Comparative study of Yiweining and gestrinone for post-operational treatment of stage 3 endometriosis","volume":"12","author":"Yang","year":"2006","journal-title":"Chinese Journal of Integrative Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009881.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"350","DOI":"10.12891\/ceog2086.2016","article-title":"Effect of mifepristone in the different treatments of endometriosis","volume":"43","author":"Zhang","year":"2016","journal-title":"Clinical & Experimental Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0022|cit22","article-title":"Endometriosis","volume-title":"Berek & Novak's Gynecology","author":"Berek","year":"2007"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.fertnstert.2011.08.021","article-title":"Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety","volume":"96","author":"Bouchard","year":"2011","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD009881.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1530\/rep.0.1240167","article-title":"Anti-proliferative effects of progesterone antagonists in the primate endometrium: a potential role for the androgen receptor","volume":"124","author":"Brenner","year":"2002","journal-title":"Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD009881.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-2005-864035","article-title":"Progesterone receptor antagonists and the endometrial antiproliferative effect","volume":"23","author":"Brenner","year":"2005","journal-title":"Seminars in Reproductive Medicine"},{"issue":"1","key":"10.1002\/14651858.CD009881.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/jcem.87.1.8140","article-title":"Daily low-dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: a double-blind randomized control trial of 2 and 5 mg per day for 120 days","volume":"87","author":"Brown","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0027|cit27","first-page":"Art. No.: CD009","article-title":"Endometriosis: an overview of Cochrane Reviews","volume":"3","author":"Brown","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1749-6632.2002.tb02761.x","article-title":"The epidemiology of endometriosis","volume":"955","author":"Cramer","year":"2002","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0889-8545(05)70302-8","article-title":"Epidemiology of endometriosis","volume":"24","author":"Eskenazi","year":"1997","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"issue":"25","key":"10.1002\/14651858.CD009881.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1000274","article-title":"Clinical practice: endometriosis","volume":"362","author":"Giudice","year":"2010","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0031|cit31","first-page":"251","article-title":"Laparoscopy in the diagnosis and management of pelvic pain in adolescents","volume":"24","author":"Goldstein","year":"1980","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0032|cit32","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0033|cit33","first-page":"551","article-title":"Mifepristone: auxiliary therapeutic use in cancer and related disorders","volume":"43","author":"Koide","year":"1998","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.2174\/0929867323666160428105310","article-title":"Current progresses and trends in the development of progesterone receptor modulators","volume":"23","author":"Li","year":"2016","journal-title":"Current Medicinal Chemistry"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0889-8545(02)00057-8","article-title":"Medical management of endometriosis-associated pain","volume":"30","author":"Mahutte","year":"2003","journal-title":"Obstetrics & Gynecology Clinics of North America"},{"issue":"5","key":"10.1002\/14651858.CD009881.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1210\/jc.2003-031945","article-title":"Low-dose mifepristone inhibits endometrial proliferation and up-regulates androgen receptor","volume":"89","author":"Narvekar","year":"2004","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/oxfordjournals.humrep.a019433","article-title":"Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms","volume":"11","author":"Neulen","year":"1996","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0002-9378(15)30003-X","article-title":"Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the pelvic cavity","volume":"14","author":"Sampson","year":"1927","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.steroids.2003.08.007","article-title":"Progesterone antagonists and progesterone receptor modulators: an overview","volume":"68","author":"Spitz","year":"2003","journal-title":"Steroids"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0040|cit40","first-page":"32","article-title":"Hormonal therapy for endometriosis: from molecular research to bedside","volume":"5","author":"Tosti","year":"2016","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD009881.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrendo.2013.255","article-title":"Endometriosis: pathogenesis and treatment","volume":"10","author":"Vercellini","year":"2014","journal-title":"Nature Reviews Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD009881.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/humrep\/dem026","article-title":"The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata","volume":"22","author":"Williams","year":"2007","journal-title":"Human Reproduction"}],"updated-by":[{"DOI":"10.1002\/14651858.cd009881.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009881.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T02:42:16Z","timestamp":1723084936000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009881.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,25]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009881.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,25]]}}}